journal
MENU ▼
Read by QxMD icon Read
search

Innovations in Clinical Neuroscience

journal
https://www.readbyqxmd.com/read/27672489/fahr-s-disease-or-fahr-s-syndrome
#1
Malathi Latha Perugula, Steven Lippmann
No abstract text is available yet for this article.
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672488/professional-liability-for-forensic-activities-liability-without-a-treatment-relationship
#2
Donna Vanderpool
No abstract text is available yet for this article.
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672487/a-case-of-treatment-resistant-depression-and-body-dysmorphic-disorder-the-role-of-electroconvulsive-therapy-revisited
#3
Ram S Mahato, Maria Chona P San Gabriel, Carrol T Longshore, David B Schnur
Body dysmorphic disorder is a common, often disabling condition, and is frequently comorbid with major depressive disorder. Selective serotonin reuptake inhibitors constitute first line set of somatic interventions but the management of refractory patients remains challenging. Electroconvulsive therapy, an often highly beneficial treatment for medication resistant-depression, is not considered an effective therapeutic alternative for treatment refractory body dysmorphic disorder. Here we present a 50-year-old woman with body dysmorphic disorder and comorbid major depressive disorder who remained incapacitated and suicidal despite several trials with selective serotonin reuptake inhibitors and antipsychotic medication...
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672486/the-potential-role-of-t-helper-cell-22-and-il-22-in-immunopathogenesis-of-multiple-sclerosis
#4
REVIEW
Nazanin Arjomand Fard, Gholamreza Azizi, Abbas Mirshafiey
Multiple sclerosis is a complex disease with many different immune cells involved in its pathogenesis. Newly identified T helper cell 22 (Th22) is a subset of CD4(+) T cells with specific properties apart from other known CD4(+) T cell subsets with distinguished function and gene expression. Th22 cells are characterized by production of a distinct profile of effector cytokines, including interleukin (IL)-22, IL-13, and tumor necrosis factor-α (TNF- α). The frequency of Th22 and related cytokine IL-22 are increased in various autoimmune diseases...
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672485/brexpiprazole-a-new-treatment-option-for-schizophrenia
#5
REVIEW
Jonathan R Scarff
Schizophrenia occurs in approximately 0.3 to 0.7 percent of the world's population and is associated with significant morbidity and mortality. Although atypical antipsychotics reduce positive and negative symptoms, they are associated with varying degrees of metabolic adverse effects. This necessitates continued development of efficacious yet metabolically favorable treatments. This article reviews brexpiprazole, a medication recently approved to treat patients with schizophrenia. Brexpiprazole was well-tolerated, and adverse reactions were statistically insignificant...
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672484/pharmaceutical-innovation-in-the-treatment-of-schizophrenia-and-mental-disorders-compared-with-other-diseases
#6
Joanna P MacEwan, Seth Seabury, Myrlene Sanon Aigbogun, Siddhesh Kamat, Emma van Eijndhoven, Clement Francois, Crystal Henderson, Leslie Citrome
OBJECTIVES: The objectives of this study were to assess the level of private and public investment in research and development of treatments for schizophrenia and other mental disorders compared to other diseases in order to present data on the economic burden and pharmaceutical innovation by disease area, and to compare the level of investment relative to burden across different diseases. DESIGN: The levels of investment and pharmaceutical innovation relative to burden across different diseases were assessed...
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672483/criminal-behavior-and-borderline-personality-correlations-among-four-measures
#7
Randy A Sansone, Martin Sellbom, Douglas A Songer
No abstract text is available yet for this article.
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27672482/gabapentin-abuse-in-a-patient-with-comorbid-mood-and-substance-use-disorders
#8
Oleg V Tcheremissine, Durga Prasad Bestha
No abstract text is available yet for this article.
July 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27803841/physician-prescribing-practices-of-vitamin-d-in-a-psychiatric-hospital
#9
Kimberly B Mulcahy, Eileen Trigoboff, Lewis Opler, Tammie Lee Demler
Vitamin D supplementation has become an increasingly popular prescribing practice, despite our limited knowledge of both the definition and degree of deficiency as well as the expected benefits or risks of exogenous administration. Many of the hypothesized benefits of vitamin D supplementation include a variety of improvements in mental health; however, these claims are not consistently or robustly supported by current research. In this paper, we provide a brief overview of what is currently known about vitamin D deficiency and about outcomes of supplementation as well as a summary of the data relative to prescribing practices for inpatients in an urban psychiatric hospital...
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800286/exit-strategy-planning-for-the-unexpected-closure-of-your-practice
#10
REVIEW
Ann McNary
No abstract text is available yet for this article.
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800285/remission-of-psychosis-in-treatment-resistant-schizophrenia-following-a-seizure-a-case-report
#11
Hena Jawaid, Sana Younus, Hanif Mesiya
The authors report a case of treatment-resistant schizophrenia in a 22-year-old woman, who, despite multiple trials of antipsychotics, did not respond to treatment. Clozapine treatment was initiated, but the patient's symptoms did not remit until after she had a clozapine-induced seizure. The authors discuss the importance in considering that electroconvulsive therapy may be effective in reducing positive and negative symptoms in patients suffering from treatment-resistant schizophrenia.
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800284/the-standard-for-clinicians-interview-in-psychiatry-scip-a-clinician-administered-tool-with-categorical-dimensional-and-numeric-output-conceptual-development-design-and-description-of-the-scip
#12
REVIEW
Ahmed Aboraya, Henry Nasrallah, Srinivas Muvvala, Ahmed El-Missiry, Hader Mansour, Cheryl Hill, Daniel Elswick, Elizabeth C Price
Existing standardized diagnostic interviews (SDIs) were designed for researchers and produce mainly categorical diagnoses. There is an urgent need for a clinician-administered tool that produces dimensional measures, in addition to categorical diagnoses. The Standard for Clinicians' Interview in Psychiatry (SCIP) is a method of assessment of psychopathology for adults. It is designed to be administered by clinicians and includes the SCIP manual and the SCIP interview. Clinicians use the SCIP questions and rate the responses according to the SCIP manual rules...
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800283/prolactin-levels-after-switching-to-paliperidone-palmitate-in-patients-with-schizophrenia
#13
Masaru Nakamura, Takahiko Nagamine, Goro Sato, Kazue Besho
Objective: The aim of this study was to investigate the tolerability and efficacy of paliperidone palmitate and its effect on the levels of prolactin in patients with schizophrenia. Method: A prospective study was carried out in 22 Japanese middle-aged patients with schizophrenia who were switched from paliperidone-extended release or risperidone long-acting injectable to paliperidone palmitate for a minimum of 12 months. Psychotic symptoms using the 18-item Brief Psychiatric Rating Scale, extrapyramidal symptoms using 9-item Drug-induced Extrapyramidal Symptoms Scale, and plasma prolactin levels using fasting blood samples were assessed at Baseline, and one, three, six, and 12 months...
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800282/digital-suicide-prevention-can-technology-become-a-game-changer
#14
REVIEW
Arshya Vahabzadeh, Ned Sahin, Amir Kalali
Suicide continues to be a leading cause of death and has been recognized as a significant public health issue. Rapid advances in data science can provide us with useful tools for suicide prevention, and help to dynamically assess suicide risk in quantitative data-driven ways. In this article, the authors highlight the most current international research in digital suicide prevention, including the use of machine learning, smartphone applications, and wearable sensor driven systems. The authors also discuss future opportunities for digital suicide prevention, and propose a novel Sensor-driven Mental State Assessment System...
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800281/decrease-in-reciprocal-fairness-feeling-of-patients-with-polydipsic-schizophrenia
#15
Takahiko Nagamine
No abstract text is available yet for this article.
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27800280/in-regard-to-autism-in-the-son-of-a-woman-with-mitochondrial-myopathy-and-dysautonomia-a-case-report
#16
Keith Fluegge
No abstract text is available yet for this article.
May 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27354928/managing-the-suicidal-patient-in-a-split-treatment-relationship
#17
Ann McNary
No abstract text is available yet for this article.
March 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27354927/a-case-of-transient-global-amnesia-a-review-and-how-it-may-shed-further-insight-into-the-neurobiology-of-delusions
#18
David R Spiegel, Aidan L Mccroskey, Branden A Deyerle
Transient global amnesia is a clinical syndrome characterized by the sudden onset of anterograde amnesia, accompanied by repetitive questioning, sometimes with a retrograde component, lasting up to 24 hours, without compromise of other neurologic function. Neuroimaging after an acutetransient global amnesia event often shows transient perturbation of specific hippocampal circuits that are involved in memory processing. Critical clinical distinctions, such as between transient global amnesia and other forms of transient amnesic episodes, as well as important clues to the underlying pathophysiologies are herein reviewed...
March 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27354926/inter-rater-reliability-assessment-of-aspect-r-a-study-pragmatic-explanatory-characterization-tool-rating
#19
Cynthia A Bossie, Larry D Alphs, David Williamson, Lian Mao, Clennon Kurut
OBJECTIVE: The increasing importance of real-world data for clinical and policy decision making is driving a need for close attention to the pragmatic versus explanatory features of trial designs. ASPECT-R (A Study Pragmatic-Explanatory Characterization Tool-Rating) is an instrument informed by the PRECIS tool, which was developed to assist researchers in designing trials that are more pragmatic or explanatory. ASPECT-R refined the PRECIS domains and includes a detailed anchored rating system...
March 2016: Innovations in Clinical Neuroscience
https://www.readbyqxmd.com/read/27354925/medical-marijuana-for-epilepsy
#20
Murali K Kolikonda, Kavitha Srinivasan, Manasa Enja, Vishwanath Sagi, Steven Lippmann
Treatment-refractory epilepsy remains an important clinical problem. There is considerable recent interest by the public and physicians in using medical marijuana or its derivatives to treat seizures. The endocannabinoid system has a role in neuronal balance and ictal control. There is clinical evidence of success in diminishing seizure frequencies with cannabis derivatives, but also documentation about exacerbating epilepsy or of no discernible effect. There are lay indications and anecdotal reports of success in attenuating the severity of epilepsy, but without solid investigational corroboration...
March 2016: Innovations in Clinical Neuroscience
journal
journal
43359
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"